Human VEGFR2/KDR Quantikine ELISA Kit

Citations are publications that use Bio-Techne products. Selected citations for Human VEGFR2/KDR Quantikine ELISA Kit include:

• Species: Human
  Sample Types: Serum
  

  V Rosiek et al. (2023-03-10), Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues Biomedicines, 2023-011(3).
  PMID:  36979820
• Species: Human
  Sample Types: Plasma
  

  L Fornaro et al. (2022-07-15), Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer American journal of cancer research, 2022-012(7):3347-3356.
  PMID:  35968330
• Species: Human
  Sample Types: Plasma
  

  C Jiguet-Jig et al. (2022-01-03), Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study Acta neuropathologica communications, 2022-010(1):1.
  PMID:  34980260
• Species: Human
  Sample Types: Serum
  

  L Zilberman et al. (2021-05-06), Residual alterations of cardiac and endothelial function in patients who recovered from Takotsubo cardiomyopathy Clinical cardiology, 2021-00(0).
  PMID:  33955558
• Species: Human
  Sample Types: Cell Culture Supernates
  

  D Dong et al. (2020-11-20), Hyperoxia sensitizes hypoxic HeLa cells to ionizing radiation by downregulating HIF?1&alpha and VEGF expression Mol Med Rep, 2020-123(1).
  PMID:  33215223
• Species: Human
  Sample Types: Serum
  

  A Waszczykow et al. (2020-11-18), Matrix Metalloproteinases MMP-2 and MMP-9, Their Inhibitors TIMP-1 and TIMP-2, Vascular Endothelial Growth Factor and sVEGFR-2 as Predictive Markers of Ischemic Retinopathy in Patients with Systemic Sclerosis-Case Series Report Int J Mol Sci, 2020-121(22).
  PMID:  33218057
• Species: Human
  Sample Types: Plasma
  

  RC Barbara et al. (2020-06-02), Divergent Impact of Breast Cancer Laterality on Clinicopathological, Angiogenic, and Hemostatic Profiles: A Potential Role of Tumor Localization in Future Outcomes J Clin Med, 2020-09(6).
  PMID:  32498398
• Species: Human
  Sample Types: Plasma
  

  C Fountzilas et al. (2020-02-10), A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma Br. J. Cancer, 2020-00(0).
  PMID:  32037403
• Species: Human
  Sample Types: Serum
  

  H Takaya et al. (2019-10-21), VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma BMC Gastroenterol, 2019-119(1):167.
  PMID:  31638892
• Species: Human
  Sample Types: Plasma
  

  E Zarychta et al. (2019-02-26), Anti-angiogenic efficacy in invasive breast carcinoma patients depends on clinicopathological determinants Adv Med Sci, 2019-064(2):216-223.
  PMID:  30818220
• Species: Human
  Sample Types: Serum
  

  J Sánchez Ra et al. (2017-07-26), Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants BMC Immunol., 2017-018(1):39.
  PMID:  28747172
• Species: Human
  Sample Types: Cell Culture Supernates
  

  Sushil Panta (2016-12-18), Low grade inflammation inhibits VEGF induced HUVECs migration in p53 dependent manner Biochem. Biophys. Res. Commun, 2016-10(0).
  PMID:  27998768
• Species: Human
  Sample Types: Plasma
  

  Günay Kalender (2016-12-14), Kinetics of circulating endothelial progenitor cells in patients undergoing carotid artery surgery Ther Clin Risk Manag, 2016-112(0):1841-1847.
  PMID:  28008262
• Species: Human
  Sample Types: Plasma
  

  Salazar R et al. (2015-02-26), A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features. BMC Cancer, 2015-015(0):60.
  PMID:  25886378
• Species: Human
  Sample Types: Serum
  

  Sallinen H et al. (2014-09-23), Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer. BMC Cancer, 2014-014(0):696.
  PMID:  25245329
• Species: Human
  Sample Types: Plasma
  

  Necchi A et al. (2013-11-14), Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracy. Br J Cancer, 2013-1110(1):26-33.
  PMID:  24231947
• Species: Human
  Sample Types: Plasma
  

  Briasoulis et al. (2013-05-29), Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study. BMC Cancer, 2013-013(1):263.
  PMID:  23718900
• Species: Human
  Sample Types: Cell Lysates, Vitreous Humor
  

  Abu El-Asrar et al. (2013-03-10), Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res, 2013-00(0):539658.
  PMID:  23671874
• Species: Human
  Sample Types: Plasma
  

  Jurgensmeier J et al. (2013-02-28), Prognostic and predictive value of VEGF, sVEGFR-2 and CEA in mCRC studies comparing cediranib, bevacizumab and chemotherapy. Br J Cancer, 2013-0108(6):1316-23.
  PMID:  23449351
• Species: Human
  Sample Types: Plasma
  

  Somlo G et al. (2013-02-12), Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004. Clin Cancer Res, 2013-019(7):1884-93.
  PMID:  23403636
• Species: Human
  Sample Types: Plasma
  

  Widemann B et al. (2012-09-07), A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clin Cancer Res, 2012-018(21):6011-22.
  PMID:  22962440
• Species: Human
  Sample Types: Serum
  

  (2012-07-17), Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study. Br. J. Cancer, 2012-0107(4):639-45.
  PMID:  22805326
• Species: Human
  Sample Types: Serum
  

  Landt S et al. (2011-08-01), Prognostic significance of angiogenic factors in uterine cervical cancer. Anticancer Res., 2011-031(8):2589-95.
  PMID:  21778309
• Species: Human
  Sample Types: Plasma
  

  Harmon CS et al. (2011-07-25), Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. J Transl Med, 2011-09(0):120.
  PMID:  21787417
• Species: Human
  Sample Types: Plasma
  

  Dubois SG et al. (2011-06-20), Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study. Clin. Cancer Res., 2011-017(15):5113-22.
  PMID:  21690570
• Species: Human
  Sample Types: Plasma
  

  de Groot JF et al. (2011-06-01), Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept. Clin. Cancer Res., 2011-017(14):4872-4881.
  PMID:  21632852
• Species: Human
  Sample Types: Plasma
  

  Loupakis F et al. (2011-03-15), Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer. Br. J. Cancer, 2011-0104(8):1262-9.
  PMID:  21407216
• Species: Human
  Sample Types: Plasma
  

  Farace F et al. (2011-03-08), Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors. Br. J. Cancer, 2011-0104(7):1144-50.
  PMID:  21386843
• Species: Human
  Sample Types: Serum
  

  Konings IR et al. (2010-09-07), Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours. Br. J. Cancer, 2010-0103(7):987-92.
  PMID:  20823884
• Species: Human
  Sample Types: Plasma
  

  Zhu AX et al. (2009-05-26), Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. J. Clin. Oncol., 2009-027(18):3027-35.
  PMID:  19470923
• Species: Human
  Sample Types: Serum
  

  Bourlev V et al. (2009-03-25), Signs of reduced angiogenic activity after surgical removal of deeply infiltrating endometriosis. Fertil. Steril., 2009-094(1):52-7.
  PMID:  19324337
• Species: Human
  Sample Types: Plasma
  

  Sallinen H et al. (2008-12-02), Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice. Mol. Ther., 2008-117(2):278-84.
  PMID:  19050699
• Species: Human
  Sample Types: Plasma
  

  Burstein HJ et al. (2008-03-17), Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane. J. Clin. Oncol., 2008-026(11):1810-6.
  PMID:  18347007
• Species: Human
  Sample Types: Plasma
  

  Saltz LB et al. (2007-10-20), Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy. J. Clin. Oncol., 2007-125(30):4793-9.
  PMID:  17947727
• Species: Human
  Sample Types: Plasma
  

  Norden-Zfoni A et al. (2007-05-01), Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. Clin. Cancer Res., 2007-013(9):2643-50.
  PMID:  17473195
• Species: Human
  Sample Types: Serum
  

  Wallner W et al. (2007-01-01), Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin. Sci., 2007-0112(1):51-7.
  PMID:  16928195

There are no citations that match your criteria.

Customer Images

• 
• (1)

• Human VEGFR2/KDR Quantikine ELISA Kit

  Name: Anonymous
  Sample Tested: HUVEC human umbilical vein endothelial cells,TeloHAEC
  Verified Customer | Posted 08/26/2020

• Human VEGF R2/KDR Quantikine ELISA Kit

  Name: Anonymous
  Sample Tested: Human cell conditioned medium
  Verified Customer | Posted 06/23/2017
  

There are no reviews that match your criteria.